Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aptar Pharma

News headline image
Aptar Pharma Continues Global Expansion with Opening of New R&D Center in France
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma’s Unidose System Delivers Enbumyst™, First U.S. FDA-Approved Intranasal Diuretic
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis
From Aptar Pharma
Via Business Wire
News headline image
Aptar’s First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon’s Otrivin® Brand
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
From Aptar Pharma
Via Business Wire
News headline image
RDD Europe 2025, Co-Organized by Aptar Pharma and RDD Online, Celebrates 20 Years
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Acquires Device Technology Assets of SipNose to Further Expand Intranasal Drug Delivery Portfolio
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Celebrates North America Capacity Expansion
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform
From Aptar Pharma
Via Business Wire
News headline image
Aptar Pharma Continues Global Expansion with North America Capacity Extension at Congers, New York Site
From Aptar Pharma
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.